neurologists

December 21, 2018December 19, 2018

Shots, Infusions, or Pills for Your MS?

Columns, The MS Wire - A Column by Ed Tobias

There are more than a dozen disease-modifying therapies available to treat MS. Some are shots, some are infusions, and some are pills. Some are more effective than others. ... Read more

March 26, 2018March 23, 2018

My Unique Primary Progressive MS Diagnosis

Columns, Faith of the Mustard Seed - a Column by Debi Wilson

I have lived with the diagnosis of primary progressive multiple sclerosis (PPMS) for almost eight years. For many years prior to that diagnosis, I was confused by what could be ... Read more

March 15, 2018May 21, 2018

New Spherix Report Finds PPMS Treatment Increased Significantly in Past Year

News, Ocrevus

Since Genentech‘s Ocrevus was approved a year ago, the treatment rate of primary progressive multiple sclerosis (PPMS) has increased significantly. However, a closer look at the data shows that other disease-modifying therapies (DMTs) ... Read more

November 17, 2017November 17, 2017

Nurses, Physicians’ Assistants Prescribe Antibody-based Therapies More Than Neurologists, Survey Shows

News

U.S. nurses and physicians’ assistants prescribe antibody-based disease-modifying therapies to their multiple sclerosis patients more than neurologists do, a survey indicates. The trend has been for the doctors to stick ... Read more

October 19, 2017October 18, 2017

How Doctors’ Gender Can Influence Opinions on Healthcare Quality

Columns, Engaging Thoughts

There are two doctors. Here’s your choice: One has a patient-centered approach to care, spends more time with you during appointments, and is more empathetic with your concerns. On ... Read more

September 18, 2017September 18, 2017

MS Patients Deserve the Best Care

Columns, Faith of the Mustard Seed - a Column by Debi Wilson

As patients, we deserve the best care for our MS and we should accept nothing less. I have had many years of difficulty trying to find adequate MS care since my diagnosis ... Read more

July 28, 2017May 21, 2018

MS Therapies: What’s Hot, What’s Not

Columns, Lemtrada, Ocrevus, The MS Wire - A Column by Ed Tobias

Ocvevus (ocrelizumab) is off to a running start, Tecfidera (dimethyl fumarate) leads the pills and the four injectable multiple sclerosis drugs are being used by fewer MS patients. But ... Read more

July 20, 2017May 21, 2018

Ocrevus Is Popular Among Neurologists, but Insurance Is a Growing Concern, Report Concludes

News, Ocrevus

Ocrevus’ market introduction is off to a stellar start, with nearly half of neurologists surveyed by Spherix Global Insights saying they are using the therapy — the first ever ... Read more

March 23, 2017March 23, 2017

Benign MS: Is It Real or a Myth?

Columns, What's Important Now -- An MS Column by Ian Franks

What is benign MS? Does it even exist? Certainly it is not one of the types of the disease often listed as making up the multiple sclerosis family. It ... Read more

January 19, 2017May 21, 2018

Reports on MS Treatment Market Show Growing Shift to Oral Therapies

News, Ocrevus

The multiple sclerosis (MS) market shifted during 2016, with oral disease-modifying therapies (DMTs) capturing a greater share and Sanofi-Genzyme’s Aubagio (teriflunomide) being poised for growth, according to a press release from Spherix ... Read more

October 13, 2016May 21, 2018

Neurologists Anticipate FDA Approval of Ocrevus as 1st Progressive MS Treatment, Survey Finds

News, Ocrevus

Neurologists in the U.S. expect — or, at least, highly anticipate — that Ocrevus (ocrelizumab), being developed by Roche as a treatment for both relapsing and progressive multiple sclerosis (MS), ... Read more

September 13, 2016September 13, 2016

Study Focuses on Caregivers and Their Often Ignored, But Key, Role in Treating MS

News

A new study from France delves further into the life of multiple sclerosis (MS) caregivers and how they are perceived by MS patients, physicians, and the caregivers themselves. The ... Read more

August 19, 2016August 20, 2016

Delays in Seeing Specialists a Growing Barrier to MS Diagnosis and Treatment

Columns, What's Important Now -- An MS Column by Ian Franks

There can be absolutely no excuse for anyone experiencing the first signs and symptoms of neurological conditions like MS having to wait a long time to see an appropriate ... Read more

Pin It on Pinterest